223 related articles for article (PubMed ID: 26940162)
1. Potential Predictors of Poor Visual Outcome in Human Leukocyte Antigen-B27-Associated Uveitis.
Verhagen FH; Brouwer AH; Kuiper JJ; Ossewaarde-van Norel J; Ten Dam-van Loon NH; de Boer JH
Am J Ophthalmol; 2016 May; 165():179-87. PubMed ID: 26940162
[TBL] [Abstract][Full Text] [Related]
2. Incidence rates and risk factors for ocular complications and vision loss in HLA-B27-associated uveitis.
Loh AR; Acharya NR
Am J Ophthalmol; 2010 Oct; 150(4):534-542.e2. PubMed ID: 20643395
[TBL] [Abstract][Full Text] [Related]
3. Human leukocyte antigen-B27-associated uveitis: long-term follow-up and gender differences.
Braakenburg AM; de Valk HW; de Boer J; Rothova A
Am J Ophthalmol; 2008 Mar; 145(3):472-9. PubMed ID: 18282492
[TBL] [Abstract][Full Text] [Related]
4. Risk for uveitis after laser in situ keratomileusis in patients positive for human leukocyte antigen-B27.
Moshirfar M; Siddharthan KS; Meyer JJ; Espandar L; Wolsey DH; Vitale AT
J Cataract Refract Surg; 2008 Jul; 34(7):1110-3. PubMed ID: 18571077
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and Visual Outcome of Glaucoma With Uveitis in a Thai Population.
Pathanapitoon K; Smitharuck S; Kunavisarut P; Rothova A
J Glaucoma; 2017 Mar; 26(3):247-252. PubMed ID: 27906814
[TBL] [Abstract][Full Text] [Related]
6. Potential predictors for frequent relapse in human leukocyte antigen-B27-associated uveitis.
Kim M; Sim YS; Choi SY; Park YH
Graefes Arch Clin Exp Ophthalmol; 2018 Aug; 256(8):1543-1549. PubMed ID: 29705838
[TBL] [Abstract][Full Text] [Related]
7. Human leukocyte antigen B27 and B51 double-positive Behçet uveitis.
Ahn JK; Park YG
Arch Ophthalmol; 2007 Oct; 125(10):1375-80. PubMed ID: 17923546
[TBL] [Abstract][Full Text] [Related]
8. The risk of newly developed visual impairment in treated normal-tension glaucoma: 10-year follow-up.
Choi YJ; Kim M; Park KH; Kim DM; Kim SH
Acta Ophthalmol; 2014 Dec; 92(8):e644-9. PubMed ID: 24698142
[TBL] [Abstract][Full Text] [Related]
9. Long term complications and vision loss in HLA-B27 uveitis.
Al-Ani HH; Sims JL; Niederer RL
Eye (Lond); 2023 Jun; 37(8):1673-1677. PubMed ID: 36038721
[TBL] [Abstract][Full Text] [Related]
10. Incidence and Risk Factors for Developing Glaucoma Among Patients with Uveitis in a University-based Tertiary Referral Center in Riyadh, Saudi Arabia.
Al Rubaie K; Al Dhahri H; Al Fawaz A; Hemachandran S; Mousa A; Mohamed AG; Al-Obeidan SA; Abu El-Asrar AM
Ocul Immunol Inflamm; 2016 Oct; 24(5):571-8. PubMed ID: 26470690
[TBL] [Abstract][Full Text] [Related]
11. Visual Prognosis and Ocular Complications in Herpetic versus HLA-B27- or Ankylosing Spondylitis-associated Anterior Uveitis.
Hoeksema L; Los LI
Ocul Immunol Inflamm; 2016 Jun; 24(3):302-12. PubMed ID: 26133756
[TBL] [Abstract][Full Text] [Related]
12. Incidence of visual improvement in uveitis cases with visual impairment caused by macular edema.
Levin MH; Pistilli M; Daniel E; Gangaputra SS; Nussenblatt RB; Rosenbaum JT; Suhler EB; Thorne JE; Foster CS; Jabs DA; Levy-Clarke GA; Kempen JH;
Ophthalmology; 2014 Feb; 121(2):588-95.e1. PubMed ID: 24332536
[TBL] [Abstract][Full Text] [Related]
13. Clinical Spectrum of HLA-B27-associated Ocular Inflammation.
Pathanapitoon K; Dodds EM; Cunningham ET; Rothova A
Ocul Immunol Inflamm; 2017 Aug; 25(4):569-576. PubMed ID: 27428361
[TBL] [Abstract][Full Text] [Related]
14. Etiological and Clinical Characteristics of HLA-B27-associated Uveitis in a Tertiary Referral Center.
İnanç M; Şimşek M; Çakar Özdal MP
Turk J Ophthalmol; 2019 Feb; 49(1):10-14. PubMed ID: 30829019
[TBL] [Abstract][Full Text] [Related]
15. Severe HLA B27-associated uveitis complicated by hypotony, serous retinal detachment, and ciliochoroidal effusion.
van der Veer EG; Keunen JE; Rothova A
Ocul Immunol Inflamm; 2014 Feb; 22(1):23-6. PubMed ID: 24063542
[TBL] [Abstract][Full Text] [Related]
16. Clinical features of HLA-B27-positive acute anterior uveitis with or without ankylosing spondylitis in a Chinese cohort.
Yang P; Wan W; Du L; Zhou Q; Qi J; Liang L; Wang C; Wu L; Kijlstra A
Br J Ophthalmol; 2018 Feb; 102(2):215-219. PubMed ID: 28607176
[TBL] [Abstract][Full Text] [Related]
17. Clinical Features and Complications of the HLA-B27-associated Acute Anterior Uveitis: A Metanalysis.
D'Ambrosio EM; La Cava M; Tortorella P; Gharbiya M; Campanella M; Iannetti L
Semin Ophthalmol; 2017; 32(6):689-701. PubMed ID: 27404944
[TBL] [Abstract][Full Text] [Related]
18. Outcomes in anterior uveitis associated with the HLA-B27 haplotype.
Power WJ; Rodriguez A; Pedroza-Seres M; Foster CS
Ophthalmology; 1998 Sep; 105(9):1646-51. PubMed ID: 9754172
[TBL] [Abstract][Full Text] [Related]
19. Visual outcomes and ocular morbidity of patients with uveitis referred to a tertiary center during first year of follow-up.
Groen F; Ramdas W; de Hoog J; Vingerling JR; Rothova A
Eye (Lond); 2016 Mar; 30(3):473-80. PubMed ID: 26742865
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of early and late immunomodulatory treatment in patients with HLA-B27-associated chronic uveitis.
Androudi S; Brazitikos P; Iaccheri B; Fiore T; Christen W; Meniconi M; Foster CS
Graefes Arch Clin Exp Ophthalmol; 2003 Dec; 241(12):1000-5. PubMed ID: 14605907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
